Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators. Dauriz M, et al. J Am Heart Assoc. 2017 Jul 5;6(7):e005156. doi: 10.1161/JAHA.116.005156. J Am Heart Assoc. 2017. PMID: 28679559 Free PMC article. Clinical Trial.
Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers.
Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi RM, Cosmi D, Scarano M, Tognoni G, Maggioni AP, Porcu M, Boni S, Cutrupi G, Tavazzi L, Latini R; GISSI-HF Investigators. Cosmi F, et al. Circ Heart Fail. 2015 May;8(3):428-37. doi: 10.1161/CIRCHEARTFAILURE.114.002091. Epub 2015 Apr 29. Circ Heart Fail. 2015. PMID: 25925415 Free article. Clinical Trial.
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure.
Askevold ET, Aukrust P, Nymo SH, Lunde IG, Kaasbøll OJ, Aakhus S, Florholmen G, Ohm IK, Strand ME, Attramadal H, Fiane A, Dahl CP, Finsen AV, Vinge LE, Christensen G, Yndestad A, Gullestad L, Latini R, Masson S, Tavazzi L; GISSI-HF Investigators; Ueland T. Askevold ET, et al. J Intern Med. 2014 Jun;275(6):621-30. doi: 10.1111/joim.12175. Epub 2014 Jan 9. J Intern Med. 2014. PMID: 24330105 Free article.
n-3 fatty acids in patients with multiple cardiovascular risk factors.
Risk and Prevention Study Collaborative Group; Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R. Risk and Prevention Study Collaborative Group, et al. N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. N Engl J Med. 2013. PMID: 23656645 Free article. Clinical Trial.
[Continuity of care in heart failure: pilot study of the Tuscany region].
Mazzuoli F, Castelli G, Nozzoli C, Verdiani V, Muscas F, Mammucari M, Condorelli G, Pecciarini G, Sarli E, Gensini GF; Ricercatori del Gruppo di Studio Pilota della Regione Toscana sulla Continuità Assistenziale nello Scompenso Cardiaco. Mazzuoli F, et al. Among authors: muscas f. G Ital Cardiol (Rome). 2012 Sep;13(9):615-21. doi: 10.1714/1133.12490. G Ital Cardiol (Rome). 2012. PMID: 22825347 Italian.
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Rischio and Prevenzione Investigators. Rischio and Prevenzione Investigators. Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68. Trials. 2010. PMID: 20509875 Free PMC article. Clinical Trial.
12 results